134 related articles for article (PubMed ID: 38928321)
1. Deficiency of Glucocerebrosidase Activity beyond Gaucher Disease: PSAP and LIMP-2 Dysfunctions.
Pavan E; Peruzzo P; Cattarossi S; Bergamin N; Bordugo A; Sechi A; Scarpa M; Biasizzo J; Colucci F; Dardis A
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928321
[TBL] [Abstract][Full Text] [Related]
2. Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells.
Ambrosi G; Ghezzi C; Zangaglia R; Levandis G; Pacchetti C; Blandini F
Neurobiol Dis; 2015 Oct; 82():235-242. PubMed ID: 26094596
[TBL] [Abstract][Full Text] [Related]
3. Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting.
Vaccaro AM; Motta M; Tatti M; Scarpa S; Masuelli L; Bhat M; Vanier MT; Tylki-Szymanska A; Salvioli R
Hum Mol Genet; 2010 Aug; 19(15):2987-97. PubMed ID: 20484222
[TBL] [Abstract][Full Text] [Related]
4. Assessment of cellular cobalamin metabolism in Gaucher disease.
Basgalupp SP; Siebert M; Ferreira C; Behringer S; Spiekerkoetter U; Hannibal L; Schwartz IVD
BMC Med Genet; 2020 Jan; 21(1):12. PubMed ID: 31931749
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal integral membrane protein-2: a new player in lysosome-related pathology.
Gonzalez A; Valeiras M; Sidransky E; Tayebi N
Mol Genet Metab; 2014 Feb; 111(2):84-91. PubMed ID: 24389070
[TBL] [Abstract][Full Text] [Related]
6. Novel beta-glucocerebrosidase chaperone compounds identified from cell-based screening reduce pathologically accumulated glucosylsphingosine in iPS-derived neuronal cells.
Naito Y; Sakamoto S; Kojima T; Homma M; Tanaka M; Matsui H
SLAS Discov; 2023 Oct; 28(7):344-349. PubMed ID: 37369311
[TBL] [Abstract][Full Text] [Related]
7. Reduced cathepsins B and D cause impaired autophagic degradation that can be almost completely restored by overexpression of these two proteases in Sap C-deficient fibroblasts.
Tatti M; Motta M; Di Bartolomeo S; Scarpa S; Cianfanelli V; Cecconi F; Salvioli R
Hum Mol Genet; 2012 Dec; 21(23):5159-73. PubMed ID: 22949512
[TBL] [Abstract][Full Text] [Related]
8. Role of LIMP-2 in the intracellular trafficking of β-glucosidase in different human cellular models.
Malini E; Zampieri S; Deganuto M; Romanello M; Sechi A; Bembi B; Dardis A
FASEB J; 2015 Sep; 29(9):3839-52. PubMed ID: 26018676
[TBL] [Abstract][Full Text] [Related]
9. Non-neuronopathic Gaucher disease due to saposin C deficiency.
Tylki-Szymańska A; Czartoryska B; Vanier MT; Poorthuis BJ; Groener JA; Ługowska A; Millat G; Vaccaro AM; Jurkiewicz E
Clin Genet; 2007 Dec; 72(6):538-42. PubMed ID: 17919309
[TBL] [Abstract][Full Text] [Related]
10. The LIMP-2/SCARB2 binding motif on acid β-glucosidase: basic and applied implications for Gaucher disease and associated neurodegenerative diseases.
Liou B; Haffey WD; Greis KD; Grabowski GA
J Biol Chem; 2014 Oct; 289(43):30063-74. PubMed ID: 25202012
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease.
Horowitz M; Braunstein H; Zimran A; Revel-Vilk S; Goker-Alpan O
Adv Drug Deliv Rev; 2022 Aug; 187():114402. PubMed ID: 35764179
[TBL] [Abstract][Full Text] [Related]
12. Fibroblasts from idiopathic Parkinson's disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2.
Thomas R; Moloney EB; Macbain ZK; Hallett PJ; Isacson O
Mol Brain; 2021 Jan; 14(1):16. PubMed ID: 33468204
[TBL] [Abstract][Full Text] [Related]
13. The role of saposin C in Gaucher disease.
Tamargo RJ; Velayati A; Goldin E; Sidransky E
Mol Genet Metab; 2012 Jul; 106(3):257-63. PubMed ID: 22652185
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of glucocerebrosidase activation and dysfunction in Gaucher disease unraveled by molecular dynamics and deep learning.
Romero R; Ramanathan A; Yuen T; Bhowmik D; Mathew M; Munshi LB; Javaid S; Bloch M; Lizneva D; Rahimova A; Khan A; Taneja C; Kim SM; Sun L; New MI; Haider S; Zaidi M
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5086-5095. PubMed ID: 30808805
[TBL] [Abstract][Full Text] [Related]
15. Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits.
Sun Y; Liou B; Ran H; Skelton MR; Williams MT; Vorhees CV; Kitatani K; Hannun YA; Witte DP; Xu YH; Grabowski GA
Hum Mol Genet; 2010 Mar; 19(6):1088-97. PubMed ID: 20047948
[TBL] [Abstract][Full Text] [Related]
16. Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome.
Ruz C; Barrero FJ; Pelegrina J; Bandrés-Ciga S; Vives F; Duran R
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233303
[TBL] [Abstract][Full Text] [Related]
17. Combination of acid β-glucosidase mutation and Saposin C deficiency in mice reveals Gba1 mutation dependent and tissue-specific disease phenotype.
Liou B; Zhang W; Fannin V; Quinn B; Ran H; Xu K; Setchell KDR; Witte D; Grabowski GA; Sun Y
Sci Rep; 2019 Apr; 9(1):5571. PubMed ID: 30944381
[TBL] [Abstract][Full Text] [Related]
18. Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease.
Magalhaes J; Gegg ME; Migdalska-Richards A; Doherty MK; Whitfield PD; Schapira AH
Hum Mol Genet; 2016 Aug; 25(16):3432-3445. PubMed ID: 27378698
[TBL] [Abstract][Full Text] [Related]
19. Gaucher disease due to saposin C deficiency is an inherited lysosomal disease caused by rapidly degraded mutant proteins.
Motta M; Camerini S; Tatti M; Casella M; Torreri P; Crescenzi M; Tartaglia M; Salvioli R
Hum Mol Genet; 2014 Nov; 23(21):5814-26. PubMed ID: 24925315
[TBL] [Abstract][Full Text] [Related]
20. A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity.
Diaz-Font A; Cormand B; Santamaria R; Vilageliu L; Grinberg D; Chabás A
Hum Genet; 2005 Jul; 117(2-3):275-7. PubMed ID: 15856305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
